
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study”, Br J Clin Pharmacol, 2021.
, “Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs”, Br J Clin Pharmacol, vol. 82, pp. 512-21, 2016.
, “Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review”, BMJ Open, vol. 6, p. e009070, 2016.
, “Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence”, BMJ Open, vol. 6, p. e010508, 2016.
, “Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
, “Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records”, J Neurol Neurosurg Psychiatry, vol. 84, pp. 1156-60, 2013.
, “Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs”, Bmj, vol. 345, p. e4388, 2012.
, “Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 482-9, 2010.
, “Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care”, Br J Clin Pharmacol, vol. 70, pp. 109-17, 2010.
, “The risk of fractures associated with thiazolidinediones: a self-controlled case-series study”, PLoS Med, vol. 6, p. e1000154, 2009.
,